Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study
Aim. The research provides a comparative analysis of the possible anticonvulsant action of different cardiac glycosides, namely: digoxin, lanatoside C, strophanthin G and corglycone. In addition, it detrmines the leading medication among the abovementioned ones by dose-dependence of its anticonvulsa...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN UK |
Publicado: |
Danylo Halytsky Lviv National Medical University
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f5cd8de1ee74f8dbc37f161e9883c72 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5f5cd8de1ee74f8dbc37f161e9883c72 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5f5cd8de1ee74f8dbc37f161e9883c722021-11-10T19:49:50ZAnticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study1029-42442415-330310.25040/aml2021.01-02.063https://doaj.org/article/5f5cd8de1ee74f8dbc37f161e9883c722021-05-01T00:00:00Zhttps://amljournal.com/index.php/journal/article/view/190https://doaj.org/toc/1029-4244https://doaj.org/toc/2415-3303Aim. The research provides a comparative analysis of the possible anticonvulsant action of different cardiac glycosides, namely: digoxin, lanatoside C, strophanthin G and corglycone. In addition, it detrmines the leading medication among the abovementioned ones by dose-dependence of its anticonvulsant action. Material and Methods. The research was performed on 66 random-bred albino male mice. The anticonvulsant effect of cardiac glycosides was studied in a baseline model of pentylenetetrazole-induced seizures. The first series of experiment evaluated the effect of cardiac glycosides on the course of model seizures in comparable doses of approximately 1/10 LD50 for the corresponding drug: digoxin, lanatoside C and strophanthin G - at a dose of 0.8 mg/kg; corglycone - at a dose of 1 mg/kg. The second series of experiments used the drug-leader, which was digoxin, in a wide dose range from 0.2 to 1.6 mg/kg. Digoxin, strophanthin G and corglycone were administered subcutaneously for 15 minutes, lanatoside C - intragastrically for 30 minutes before the induction of experimental seizures. Convulsive agent - pentylenetetrazole in the form of an aqueous solution was administered to animals subcutaneously at a dose of 80 mg/kg. Results and Discussion. Digoxin at a dose of 0.8 mg/kg under conditions of pentylenetetrazole-induced seizures shows a pronounced anticonvulsant activity: it is the only one among the studied cardiac glycosides that probably reduces lethality. In addition, digoxin prolongs the latency period of the first attacks, and reduces the number of clonic-tonic paroxysms in 1 mouse. Moderate anticonvulsant properties of lanatoside C were found both by a statistically significant decrease in the number of clonic-tonic seizures in 1 mouse, and by a significant reduction in the duration of the convulsive period. Although strophanthin G is unlikely to affect lethality, it moderately reduces the severity of pentylenetetrazole-induced seizures in mice, as evidenced by a statistically significant prolongation of the latency period of the first seizures, as well as a decrease in the number of clonic-tonic seizures in 1 mouse and the duration of seizures. Prophylactic administration of corglycone only prolongs the latency period of seizures and significantly reduces the number of clonic-tonic seizures in 1 mouse. The results of the dose-dependence study of digoxin anticonvulsant action show a clear anticonvulsant potential of this cardiac glycoside in a wide range of doses - from 0.2 to 1.6 mg/kg - with a maximum effect at a dose of 0.8 mg/kg. Conclusions. It was found that cardiac glycosides have a different severity of anticonvulsant effect: the most powerful anticonvulsant effect is due to digoxin, lanatoside C and strophanthin G have moderate properties, and the least pronounced effect is characteristic to corglycone. In addition, it was determined that digoxin exhibits anticonvulsant properties in a wide range of doses, and has the most pronounced anticonvulsant effect at a dose of 0.8 mg/kg. The obtained results substantiate the expediency of further in-depth study of digoxin as an anticonvulsant medicine.V.V. TsyvuninS.Yu. Shtrygol'D.V. Shtrygol'D.P. KavraiskyiDanylo Halytsky Lviv National Medical Universityarticlecardiac glycosides, digoxin, anticonvulsant activity, experimental seizures, miceMedicine (General)R5-920ENUKActa Medica Leopoliensia, Vol 27, Iss 1-2, Pp 63-69 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN UK |
topic |
cardiac glycosides, digoxin, anticonvulsant activity, experimental seizures, mice Medicine (General) R5-920 |
spellingShingle |
cardiac glycosides, digoxin, anticonvulsant activity, experimental seizures, mice Medicine (General) R5-920 V.V. Tsyvunin S.Yu. Shtrygol' D.V. Shtrygol' D.P. Kavraiskyi Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study |
description |
Aim. The research provides a comparative analysis of the possible anticonvulsant action of different cardiac glycosides, namely: digoxin, lanatoside C, strophanthin G and corglycone. In addition, it detrmines the leading medication among the abovementioned ones by dose-dependence of its anticonvulsant action.
Material and Methods. The research was performed on 66 random-bred albino male mice. The anticonvulsant effect of cardiac glycosides was studied in a baseline model of pentylenetetrazole-induced seizures. The first series of experiment evaluated the effect of cardiac glycosides on the course of model seizures in comparable doses of approximately 1/10 LD50 for the corresponding drug: digoxin, lanatoside C and strophanthin G - at a dose of 0.8 mg/kg; corglycone - at a dose of 1 mg/kg. The second series of experiments used the drug-leader, which was digoxin, in a wide dose range from 0.2 to 1.6 mg/kg. Digoxin, strophanthin G and corglycone were administered subcutaneously for 15 minutes, lanatoside C - intragastrically for 30 minutes before the induction of experimental seizures. Convulsive agent - pentylenetetrazole in the form of an aqueous solution was administered to animals subcutaneously at a dose of 80 mg/kg.
Results and Discussion. Digoxin at a dose of 0.8 mg/kg under conditions of pentylenetetrazole-induced seizures shows a pronounced anticonvulsant activity: it is the only one among the studied cardiac glycosides that probably reduces lethality. In addition, digoxin prolongs the latency period of the first attacks, and reduces the number of clonic-tonic paroxysms in 1 mouse. Moderate anticonvulsant properties of lanatoside C were found both by a statistically significant decrease in the number of clonic-tonic seizures in 1 mouse, and by a significant reduction in the duration of the convulsive period. Although strophanthin G is unlikely to affect lethality, it moderately reduces the severity of pentylenetetrazole-induced seizures in mice, as evidenced by a statistically significant prolongation of the latency period of the first seizures, as well as a decrease in the number of clonic-tonic seizures in 1 mouse and the duration of seizures. Prophylactic administration of corglycone only prolongs the latency period of seizures and significantly reduces the number of clonic-tonic seizures in 1 mouse. The results of the dose-dependence study of digoxin anticonvulsant action show a clear anticonvulsant potential of this cardiac glycoside in a wide range of doses - from 0.2 to 1.6 mg/kg - with a maximum effect at a dose of 0.8 mg/kg.
Conclusions. It was found that cardiac glycosides have a different severity of anticonvulsant effect: the most powerful anticonvulsant effect is due to digoxin, lanatoside C and strophanthin G have moderate properties, and the least pronounced effect is characteristic to corglycone. In addition, it was determined that digoxin exhibits anticonvulsant properties in a wide range of doses, and has the most pronounced anticonvulsant effect at a dose of 0.8 mg/kg. The obtained results substantiate the expediency of further in-depth study of digoxin as an anticonvulsant medicine. |
format |
article |
author |
V.V. Tsyvunin S.Yu. Shtrygol' D.V. Shtrygol' D.P. Kavraiskyi |
author_facet |
V.V. Tsyvunin S.Yu. Shtrygol' D.V. Shtrygol' D.P. Kavraiskyi |
author_sort |
V.V. Tsyvunin |
title |
Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study |
title_short |
Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study |
title_full |
Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study |
title_fullStr |
Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study |
title_full_unstemmed |
Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study |
title_sort |
anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study |
publisher |
Danylo Halytsky Lviv National Medical University |
publishDate |
2021 |
url |
https://doaj.org/article/5f5cd8de1ee74f8dbc37f161e9883c72 |
work_keys_str_mv |
AT vvtsyvunin anticonvulsivepotentialofcardiacglycosidesunderconditionsofpentilentetrazoleinducedseizuresinmicecomparativestudy AT syushtrygol anticonvulsivepotentialofcardiacglycosidesunderconditionsofpentilentetrazoleinducedseizuresinmicecomparativestudy AT dvshtrygol anticonvulsivepotentialofcardiacglycosidesunderconditionsofpentilentetrazoleinducedseizuresinmicecomparativestudy AT dpkavraiskyi anticonvulsivepotentialofcardiacglycosidesunderconditionsofpentilentetrazoleinducedseizuresinmicecomparativestudy |
_version_ |
1718439781802704896 |